Clinical Trial

Time Restricted Eating in Patients With Microalbuminuria

Study acronym: TREK
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-12.
Status change: Not Yet Recruiting → Recruiting 2026-07-10
Trial Details
NCT Number NCT06884059
Lead Sponsor University of California, San Diego
Collaborators: Salk Institute for Biological Studies
Conditions Type 2 Diabetes Mellitus (T2DM), Time Restricted Eating, Microalbuminuria
Enrollment 25 participants
Start Date 2026-07
Primary Completion 2027-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-14